ResMed has completed the acquisition of non-invasive ventilation and sleep-disordered breathing medical devices and accessories provider, Curative Medical.

Financial terms of the deal, which was announced first in July, have not been disclosed.

Established in 2008, Curative designs and produces medical devices for sleep-disordered breathing and chronic obstructive pulmonary disease.

The firm has a manufacturing base in Suzhou, China, as well as offices in Beijing, Germany and the US. It also has a distributor network across China and in other select markets.

ResMed CEO Mick Farrell said: "By joining forces with Curative Medical we expand our combined reach in the growing respiratory medical device market in China.

"Together we will focus on improving patient quality of life while reducing the cost of care for sleep-disordered breathing and chronic obstructive pulmonary disease."

ResMed China and Curative Medical will operate independently, while Curative will continue to invest in R&D, manufacturing, marketing and sales teams in China.

Curative will maintain its name, brands and innovative offerings developed for Chinese market and other global markets.

Under the deal, Curative employees, including the founder and CEO Jason Sun, will offer services as members of the combined ResMed and Curative team.

ResMed, which has operations in around 100 countries, develops devices and treatments for sleep-disordered breathing, chronic obstructive pulmonary disease and other chronic diseases.